# Topical GHK-Cu Gel for Acute Skin Wound Healing

> **NCT07437586** · PHASE2 · RECRUITING · sponsor: **Hudson Biotech** · enrollment: 60 (estimated)

## Conditions studied

- Acute Standardized Cutaneous Wounds (Punch-biopsy Wounds)

## Interventions

- **DRUG:** GHK-Cu Gel (Copper(II)-peptide complex)
- **DRUG:** vehicle Gel (placebo comparator)

## Key facts

- **NCT ID:** NCT07437586
- **Lead sponsor:** Hudson Biotech
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-02
- **Primary completion:** 2027-02-14
- **Final completion:** 2028-03-17
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07437586

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07437586, "Topical GHK-Cu Gel for Acute Skin Wound Healing". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07437586. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*